Skip to content
Research Article Open access CC BY 4.0

In-vitro Antimicrobial Activity of the Combined Effect of Kalanchoe crenata and Vernonia amygdalina on Salmonella Species

Emmanuel Effah-Yeboah, Emmanuel Agyapong Asare, Gadafi Iddrisu Balali, Vincent Aboagye, Kofi Sarpong, Mohammed Taufiq, Abdul-Malik Bawah

Annual Research & Review in Biology · pp. 93–102 · Published 4 Dec 2021

10.9734/arrb/2021/v36i1130455

Abstract

Introduction: The breakthrough in the treatment of pathogenic diseases was the unearthing of naturally occurring antipathogenic agents or antibiotics. There have been upsurges in antibiotic-resistant strains of clinically important pathogens, which made way to the emergence of new-fangled bacterial strains that are multi-resistant. The major aim of scientists is to develop new antibiotics or other therapeutic strategies at a pace greater than that at which bacteria are developing resistance. The development of resistance to first-line antimicrobial therapies made way to recommendations for combination therapies for the treatment of some infections and some of this form of chemotherapy seems to be very successful. Objectives: This research was carried out to determine the effect of Kalanchoe crenata extracts on Salmonella typhi load. Also, to assess the potency of the extract of Vernonia amygdalina on Salmonella typhi and finally to ascertain the effect of the combined extract of Kalanchoe crenata and Vernonia amygdalina on Salmonella typhi. Methods: In this research, Salmonella typhi was exposed to a crude extract of Kalanchoe crenata and Vernonia amygdalina and also the combination of the two extracts. Agar wells diffusion method was employed. Results: The combined effect was not sensitive to the Salmonella strain. The Salmonella strain was resistant to V. amygdalina than to K. crenata. K. cranata had the strongest activity against S. typhi with its highest zone of growth inhibition of 20 mm and lowest zone of inhibition of 7 mm while V. amygdalina produced a consistent zone of growth inhibition of 5-6 mm; The combined effect produced a zone inhibition diameter only at the 100 mg/ml with a zone of inhibition value of 14 mm. The subsequent lower concentrations did not show any activity against the microbes. At P-value = 0.05 two-way ANOVA statistics exhibited significant differences amongst the effects produced by the different extracts, though there were no substantial differences in the effects produced by the various concentrations. Conclusion: The Salmonella strain was resistant to V. amygdalina than to K. crenata. At P-value = 0.05 there was a substantial difference in the sensitivity of the bacteria to the different extracts.

Antimicrobial inhibition sensitivity Salmonella typhi zones of inhibition and extracts

References (40)

  1. 1 Antimicrobial agents and chemotherapy—1969 [DOI]
  2. 2 The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria [DOI]
  3. 3 Phytochemical Screening and Antioxidant Activities of Some Selected Medicinal Plants Used for Malaria Therapy in Southwestern Nigeria [DOI]
  4. 4 Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria [DOI]
  5. 5 Water, sanitation, hygiene and enteric infections in children [DOI]
  6. 6 Medicinal Plants Useful For Malaria Therapy In Okeigbo, Ondo State, Southwest Nigeria [DOI]
  7. 7 The battle against multi-resistant strains: Renaissance of antimicrobial essential oils as a promising force to fight hospital-acquired infections [DOI]
  8. 8 Multidrug-resistant typhoid fever: a review [DOI]
  9. 9 Antibacterial activity of plants used in traditional medicines of Ghana with particular reference to MRSA [DOI]
  10. 10 Ethnopharmacological survey and in vitro evaluation of wound-healing plants used in South-western Nigeria [DOI]
  11. 11 Vernonia amygdalina, an ethnoveterinary and ethnomedical used green vegetable with multiple bio-activities. [DOI]
  12. 12 Extensively Drug‐Resistant (XDR) Typhoid: Evolution, Prevention, and Its Management [DOI]
  13. 13 In vitro antimicrobial activity of crude extracts from plants Bryophyllum pinnatum and Kalanchoe crenata.
  14. 14 Structure-Function Characterization and Optimization of a Plant-Derived Antibacterial Peptide [DOI]
  15. 15 Acute diuretic effect of aqueous extract of Retama raetam in normal rats [DOI]
  16. 16 Effect of Regulation and Education on Reptile-associated Salmonellosis [DOI]
  17. 17 Mims' Pathogenesis of Infectious Disease [DOI]
  18. 18 Phytochemical analysis and proximate composition of Vernonia amygdalina [DOI]
  19. 19 Antimicrobial Effect of Phyllanthus amarus and Parquetina nigrescens on Salmonella typhi [DOI]
  20. 20 Antibacterial activity of water, ethanol and methanol extracts of Ocimumgratissimum, Vernonia amygdalina and Aframomum melegueta
  21. 21 Bacterial activity of crude extracts of Vernonia amygdalina on clinical isolates [DOI]
  22. 22 Chromosomal and plasmid-mediated fluoroquinolone resistance in human Salmonella enterica infection in Ghana [DOI]
  23. 23 Purification and identification of antibacterial compounds from Euclea crispa subsp. crispa (Ebenaceae) leaves [DOI]
  24. 24 Changes in microbial community structures due to varying operational conditions in the anaerobic digestion of oxytetracycline-medicated cow manure [DOI]
  25. 25 In Vitro Antibacterial Effects of Crateva adansonii, Vernonia amygdalina and Sesamum radiatum Used for the Treatment of Infectious Diarrhoeas in Benin [DOI]
  26. 26 Pharmacognostical Profile of Selected Medicinal Plants [DOI]
  27. 27 Antimicrobial activity of Vernonia amygdalina on selected urinary tract pathogens [DOI]
  28. 28 Antimicrobial Activities of Vernonia amygdalina Against Oral Microbes
  29. 29 Current Fluoroquinolone Susceptibility Criteria for Salmonella Needs Re-evaluation [DOI]
  30. 30 Kinetics of Minimum Inhibitory Concentration, Minimum Bactericidal Concentration and Minimum Fungicidal Concentration of Vernonia amygdalina (Bitter leaf) on Microorganisms Isolated from Wound Infections
  31. 31 The Promising Viral Threat to Bacterial Resistance: the Uncertain Patentability of Phage Therapeutics and the Necessity of Alternative Incentives.
  32. 32 Modulation of cholinergic, monoaminergic, and purinergic enzymes of the brain functions by bitter (Vernonia amygdalina) and water bitter (Struchium sparganophora) leaves extracts: comparison of phenolic constituents versus nootropic potentials [DOI]
  33. 33 Antibacterial Activityof Aqueous And Ethanolic Leaf Extracts Of Vernonia Amygdalina On Selected Species Of Gram Positive And Gram Negative Bacteria [DOI]
  34. 34 Prevalence of salmonella agglutinins among patients attending hospitals in biu, Borno State, Nigeria
  35. 35 PREVALENCE OF DIARRHOEA AGENTS AND THE IN-VITRO EFFECTS OF THREE PLANT EXTRACTS ON THE GROWTH OF THE ISOLATES
  36. 36 African Journal of Microbiology Research [DOI]
  37. 37 African Journal of Traditional, Complementary and Alternative Medicines [DOI]
  38. 38 African Journal of Biomedical Research [DOI]
  39. 39 Essential microbiology [DOI]
  40. 40 Journal of Microbiology and Antimicrobials [DOI]

Cited by 6

Bioactive compounds from fermented Vernonia amygdalina leaf: Potent antibiotics against multidrug-resistant Escherichia coli and Salmonella typhi

Adeleke Kazeem Atunnise, Ibukun Temitope Sossou, Peace Sekani Peters · In Silico Pharmacology · 2024

Showing 2 of 6 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

53

Page views

0

PDF downloads

18

Outbound clicks

6

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.